Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis.

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

September 12, 2017

Primary Completion Date

September 6, 2022

Study Completion Date

September 6, 2022

Conditions
Osteoarthritis
Interventions
BIOLOGICAL

LNA043

LNA043 intra-articular injection

OTHER

Placebo

Placebo intra-articular injection

Trial Locations (19)

2650

Novartis Investigative Site, Hvidovre

19140

Novartis Investigative Site, Philadelphia

29301

Novartis Investigative Site, Mladá Boleslav

33014

Novartis Investigative Site, Miami Lakes

33351

Novartis Investigative Site, Sunrise

33603

Novartis Investigative Site, Tampa

53002

Novartis Investigative Site, Pardubice

60612

Novartis Investigative Site, Chicago

63141

Novartis Investigative Site, St Louis

66250

Novartis Investigative Site, Brno

83702

Novartis Investigative Site, Boise

85053

Novartis Investigative Site, Phoenix

89119

Novartis Investigative Site, Las Vegas

91942

Novartis Investigative Site, La Mesa

95821

Novartis Investigative Site, Sacramento

272 59

Novartis Investigative Site, Kladno

280 02

Novartis Investigative Site, Kolín

190 00

Novartis Investigative Site, Prague

DK 8000

Novartis Investigative Site, Aarhus C

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY